Research

Treatment Intensification in a Hypertension Telemanagement Trial – Clinical Inertia or Good Clinical Judgment?

Clinical inertia represents a barrier to hypertension management. As part of a hypertension tele-management trial designed to overcome clinical inertia.

Read more

What Insights Will You Gain?

This study examined physician responses to a hypertension telemonitoring program designed to reduce "clinical inertia" (failure to intensify treatment when blood pressure is high). Among 922 eligible alerts for elevated home blood pressure across 296 patients, physicians intensified treatment only 40.6% of the time. The most common reason for not intensifying was that physicians judged the blood pressure "acceptable" and notably, these cases had lower average readings (135.3/76.7 vs. 143.2/80.6 mmHg) and were less likely to trigger repeat alerts, meaning patients' blood pressure stayed controlled afterward. This challenges the assumption that not intensifying treatment always equals poor care. It shows that physician judgment calls to hold off on medication changes were often clinically sound rather than a failure of the system the "inertia" wasn't necessarily bad. More broadly, it highlights the limits of alert-driven telemedicine: automated triggers can flag a problem, but they can't fully substitute for clinical nuance, and treating every alert as something requiring action could actually lead to overtreatment.